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K. S. Chan,2 B. J. Zheng,1 J. S. M. Peiris,1 J. J. Y. Sung,4 and K. Y. Yuen1
1Centre of Infection, Queen Mary Hospital, The University of Hong Kong, 2Department of Medicine, United Christian Hospital, 3Department of
Medicine and Geriatrics, Caritas Medical Centre, and 4Department of Medicine and Therapeutics, Prince of Wales Hospital, Hong Kong Special
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The role of severe acute respiratory syndrome (SARS) coronavirus as an enteric pathogen was investigated in
a cohort of 142 patients with SARS who were treated with a standard treatment protocol. Data from daily
hematological, biochemical, radiological, and microbiological investigations were prospectively collected, and
the correlation of these findings with diarrhea was retrospectively analyzed. Sixty-nine patients (48.6%) de-
veloped diarrhea at a mean ( standard deviation [SD]) of days after the onset of symptoms. The7.6 2.6
diarrhea was most severe at a mean (SD) of days after onset, with a maximum frequency of 248.8 2.4
episodes per day (median, 5 episodes; range, 3–24 episodes). A higher mean virus load in nasopharyngeal
specimens obtained on day 10 after the onset of symptoms was significantly associated with the occurrence
of diarrhea (3.1 log10 vs. 1.8 log10 copies/mL; ) and mortality (6.2 vs. 1.7 log10 copies/mL; ).Pp .01 P ! .01
However, diarrhea was not associated with mortality. The lung and the gastrointestinal tract may react dif-
ferently to SARS coronavirus infection. Additional investigation of the role of SARS coronavirus in the path-
ogenesis of diarrhea in patients with SARS should be conducted.
The severe acute respiratory syndrome (SARS) pan-
demic has affected 18000 patients, with 774 fatalities
[1]. SARS is caused by a novel coronavirus, which was
consistently isolated from patients with SARS who had
subsequent seroconversion [2–4]. Similar histopatho-
logical findings of SARS and seroconversion have been
reproduced in cynomolgus macaques (Macaca fasci-
cularis) that were artificially inoculated with the same
SARS coronavirus [5]. Subsequent detailed histopath-
ological study of these infected macaques confirmed
that the inflammatory changes were confined to the
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lungs [6]. Thus, SARS is largely regarded as a novel
viral pneumonia. However, in a prospective clinical
study of a cohort of patients with SARS, diarrhea was
noted in 1% of patients at hospital admission and in
73% during hospitalization [7]. Viral genomes or the
virus could be detected by RT-PCR or cell culture of
stool samples obtained from these patients [8]. As il-
lustrated by the example of enterovirus infection, shed-
ding of virus in stool does not necessarily imply the
presence of disease in the intestinal tract. Nevertheless,
presence of numerous coronavirus particles was dem-
onstrated in the terminal ileum and colon in a patient
with SARS who had diarrhea [9]. It would be interesting
to know whether the SARS coronavirus indeed causes
diarrhea, because histopathological examination of in-
testinal biopsy specimens does not reveal any inflam-
matory or cytolytic damages.
We have previously shown that specimens obtained
from the nasopharynx are useful for the diagnosis of
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Table 1. Clinical symptoms and signs for 142












Sore throat 13 (9.2)
Cough 41 (28.9)
Shortness of breath 4 (2.8)
Diarrhea 15 (10.6)
Sign
Oxygen desaturationa 2 (1.4)
Tachypneab 11 (7.7)
Tachycardiac 48 (33.8)
a Oxygen saturation, oximetry, !90%.
b Respiratory rate, 120 breaths/min.
c Heart rate, 1100 beats/min.
rotavirus infection in children [10]. This is not unexpected,
because an earlier study also demonstrated the presence of
rotavirus in nasopharyngeal secretions from children with up-
per respiratory tract infection [11]. In this retrospective study,
we attempt to correlate the virus load of SARS coronavirus
shedding from the nasopharynx, the upper end of the aero-
digestive tract, with the presence of diarrhea in a cohort of
patients with SARS. Demographic characteristics, clinical fea-
tures, and hematological and radiological findings of patients
with SARS who had or did not have diarrhea were collected
and analyzed.
PATIENTS, MATERIALS, AND METHODS
The clinical records for all 142 patients whose cases fulfilled
the modified World Health Organization definition of SARS
[4, 7] and who were treated at the United Christian Hospital
and Caritas Medical Centre (Hong Kong) were analyzed. The
daily clinical findings from history and physical examinations
and hematological, biochemical, radiological, and microbio-
logical investigations were prospectively collected and analyzed.
In brief, the case definition includes fever (temperature,
38C), cough or shortness of breath, and new pulmonary
infiltrates noted on chest radiographs or high-resolution CT,
in the absence of an alternative diagnosis to explain the clinical
presentation. Some of the clinical and virological results for the
first 75 patients were previously reported [7]. All patients were
treated with amoxicillin-clavulanate (1.2 g q8h iv) and azith-
romycin (500 mg q.d. po). In patients with a known allergy to
penicillin, we administered 500 mg of oral levofloxacin every
24 h. As soon as the diagnosis of SARS was established, ribavirin
(a 4-g oral loading dose, followed by 1.2 g q8h or 8 mg/kg q8h
iv if the patient could not tolerate oral treatment) was given
for 14 days, in addition to a tailing regimen of hydrocortisone
(starting dose, 200 mg q8h iv) for 10 days, followed by oral
prednisolone (1 mg/kg for 5 days, 0.5 mg/kg for 3 days, and
0.25 mg/kg for 3 days) for 11 days. Pulses of methylpredni-
solone (500–1000 mg q.d. iv for up to 3 g) were administered
to patients with clinical deterioration. All hepatitis B surface
antigen–positive patients were given prophylactic lamivudine
(100 mg q.d. po) while taking corticosteroids.
Patients were prospectively monitored for development of
diarrhea during hospitalization. Diarrhea was defined as 3
bowel movements per day for 2 consecutive days. The oc-
currence of diarrhea in relation to the onset of symptoms of
SARS, the frequency of bowel movements, and the duration of
diarrhea were recorded. Investigation for other causes of di-
arrhea was performed, including culture for Clostridium diffi-
cile, cell culture assay for detection C. difficile cytotoxin, and
ELISA (IDEIA Rotavirus; DAKO) for detection of rotavirus.
For the diagnosis of coronavirus infection, nasopharyngeal
specimens and serum samples were obtained at hospital ad-
mission. The convalescent-phase serum sample was taken 14–
28 days after the onset of symptoms. For all patients, qualitative
and quantitative RT-PCRs for SARS coronavirus were retro-
spectively performed using the nasopharyngeal specimens ob-
tained at admission and 10 days after the onset of symptoms.
Stool and urine specimens were obtained for RT-PCR during
the hospital stay. All virological diagnostic protocols, including
performance of qualitative and quantitative RT-PCRs, rapid
viral antigen detection tests, viral cultures, immunofluorescent
antibody tests for detection for IgG seroconversion against
SARS-associated coronavirus, and other microbiological diag-
nostic evaluations, were done in the manner described in our
previous publications [4, 7].
Statistical analysis. All data were calculated from the day
of onset of clinical symptoms. We compared the demographic
characteristics and laboratory values for patients with and with-
out diarrhea by means of Fisher’s exact test for categorical
variables and Student’s t test or the Mann-Whitney U test for
continuous variables. A 2-tailed P value of !.05 was considered
to be statistically significant. We used SPSS software, version
11.0 (SPSS), for all analyses.
RESULTS
Of the 142 patients recruited in this study, 138 (97.2%) were
ethnic Chinese, and the remaining patients were Filipinos. The
Table 2. Hematological and biochemical findings for 142 patients with severe acute respiratory syndrome at




of symptoms Normal range
Hemoglobin level 11.5–16.5 g/dL
Mean g/dL  SD 13.4  0.15 13.1  0.79
No. (%) of patients with anemia 13 (9.2) 23 (16.2)
Hematocrit 0.35–0.45
Mean  SD 0.40  0.44 0.37  0.43
No. (%) of patients … …
Total WBC count 4–11 109 cells/L
Mean 109 cells/L  SD 6.2  2.3 13.9  4.4
No. (%) of patients with leukocytosis 4 (2.8) 88 (62.0)
Neutrophil count 2.0–7.5  109 neutrophils/L
Mean  109 neutrophils/L  SD 5.2  2.0 12.3  4.4
No. (%) of patients with neutrophilia 21 (14.8) 118 (83.1)
Lymphocyte count 1.5–4.0  109 lymphocytes/L
Mean  109 lymphocytes/L  SD 0.92  0.50 0.57  0.26
No (%) of patients with severe lymphopeniaa 82 (57.7) 109 (76.8)
Platelet count 150–400  109 platelets/L
Mean  109 platelets/L  SD 173  50 233  64
No. (%) of patients with thrombocytopenia 44 (31.0) 8 (5.6)
Sodium level 136–148 mmol/L
Mean mmol/L  SD 137  4 143  3
No. (%) of patients with hyponatremia 27 (19.0) 3 (2.1)
Potassium level 3.4–3.6 mmol/L
Mean mmol/L  SD 3.9  0.4 3.4  0.5
No. (%) of patients with hypokalemia 15 (10.6) 65 (45.8)
Urea level 2.5–6.4 mmol/L
Mean mmol/L  SD 4.1  1.3 5.3  1.8
No. (%) of patients with elevated urea level 5 (3.5) 24 (16.9)
Creatinine level 60–106 mmol/L
Mean mmol/L  SD 86  16 72  12
No. (%) of patients with elevated creatinine level 14 (9.9) 1 (0.7)
ALT level 5–41 IU/L
Mean IU/L  SD 31  34 55  47
No. (%) of patients with elevated ALT level 27 (19.0) 59 (41.5)
AST level 12–38 IU/L
Mean IU/L  SD 36  30 25  16
No. (%) of patients with elevated AST level 30 (21.1) 20 (14.1)
Albumin level
Mean g/L  SD 40  4 32  3 42–54 g/L
No. (%) of patients with low albumin level 77 (54.2) 142 (100)
CPK level 38–174 IU/L
Mean IU/L  SD 173  213 74  75
No. (%) of patients with elevated CPK level 36 (25.4) 7 (4.9)
LDH level 200–360 IU/L
Mean IU/L  SD 376  151 489  204
No. (%) of patients with elevated LDH level 39 (27.5) 66 (46.5)
NOTE. ALT, alanine aminotransferase; AST, aspartate aminotransferase; CPK, creatinine kinase; LDH, lactate dehydrogenase.
a Lymphocyte count, ! lymphocytes/L.9110
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Table 3. Extent of radiological involvement and microbiological findings for
142 patients with severe acute respiratory syndrome (SARS).




Abnormal chest radiograph finding 108 (76.1)
Multizone involvement 29 (20.4)
Single-zone involvement 79 (55.6)
Right lower zone lesion 27
Right middle zone lesion 13
Right upper zone lesion 6
Left lower zone lesion 15
Left middle zone lesion 9
Left upper zone lesion 9
Abnormal finding of thorax CTa 34 (23.9)
Multi-zone involvement 15 (10.6)
Single-zone involvement 19 (13.4)
Right lower zone lesion 1
Right middle zone lesion 1
Right upper zone lesion 4
Left lower zone lesion 12
Left middle zone lesion 1
Left upper zone lesion 0
Subpleural lesions 8 (5.6)
Predominant radiological lesions
Consolidation 16 (11.3)
Ground-glass appearance 6 (4.2)
Combination of consolidation and ground-glass appearance 12 (8.5)
Microbiological examination
Four-fold increase in antibody against SARS coronavirus 130 (91.5)
Positive qualitative RT-PCR result for any clinical specimen 109 (76.8)
Nasopharyngeal specimen obtained at hospital admission 45 (31.7)
Nasopharyngeal specimen obtained during hospitalization 71 (50.0)
Stool specimen obtained during hospitalization 101 (71.1)
Urine specimen obtained during hospitalization 39 (27.5)
Either serological or RT-PCR–based confirmation of SARS coronavirus 137 (96.5)
a Performed for 34 patients with apparently normal chest radiograph findings.
patients were admitted to the hospital days after onset2.4 1.8
of symptoms. There were 56 male and 86 female patients (ratio,
0.65:1), and the mean age was years (range, 20–40.4 13.9
86 years). Eighty-six patients (60.6%) were household contacts
of patients with SARS, and 28 (19.7%) were health care workers.
For 28 patients (19.7%), the source of SARS infection could
not be traced. Underlying chronic disease was found in 21
patients (14.8%), of whom 12 were chronic hepatitis B carriers
without stigmata of chronic liver disease, 3 had diabetes mel-
litus, 3 had ischemic heart disease, 2 had malignancies, and 1
had chronic obstructive airway disease.
The clinical symptoms and signs of these 142 patients are
shown in table 1. Common presenting symptoms included sys-
temic upset, such as fever (96.5% of patients), chills (67.6%),
and myalgia (57.7%). One-third of patients had tachycardia
noted at admission. With regard to hematological and bio-
chemical manifestations of disease, severe lymphopenia (lym-
phocyte count, ! lymphocytes/L) was present in 82 pa-91 10
tients (57.7%), and thrombocytopenia was present in 44
patients (31.0%) (table 2). Hyponatremia was noted in 27 pa-
tients (19%). Elevations in alanine aminotransferase, aspartate
aminotransferase, creatinine kinase, and lactate dehydrogenase
levels were noted in 27 (19.0%), 30 (21.1%), 36 (25.4%), and
39 (27.5%) of the patients, respectively. Initial chest radiograph
findings were abnormal for 108 patients (76.1%), and multi-
zone involvement was found in 29 of them (table 3). In 79
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Figure 1. Percentage of patients with severe acute respiratory syndrome who had diarrhea during hospitalization
patients who presented with single-zone lesions, the right lower
and left lower zones were more commonly involved than were
the other zones. Thoracic CT was performed for 34 patients
with initial apparently normal chest radiograph findings. The
lesions were mostly confined to the retrocardiac region in the
left lower lobes.
With regard to the microbiological evaluation for SARS co-
ronavirus, 137 patients (96.5%) had either a 4-fold increase in
antibody to SARS coronavirus or positive results of RT-PCR
of nasopharyngeal, stool, or urine specimens (table 3). Four-
fold increases in antibody titers to SARS coronavirus were
found in 26 of 28 patients who did not have any history of
epidemiological exposure, and RT-PCR results were positive
for the remaining 2 patients.
During the course of infection, diarrhea occurred in 69 pa-
tients (48.6%). The distribution of episodes of diarrhea during
the first 3 weeks of hospitalization is shown in figure 1. Diarrhea
occurred days after the onset of symptoms and be-7.6 2.6
came most severe on day , with a maximum frequency8.8 2.4
of 24 episodes per day (median, 5 episodes per day; range, 3–
24 episodes per day). The diarrhea lasted for a duration of
days in this cohort, resulting in prerenal azotemia in3.8 2.3
6 patients and electrolyte disturbances in 39 patients. The di-
arrhea was rather painless, with no blood or mucus present in
the stool for any patients. None of the patients had positive
results of culture for C. difficile or cell culture assay for C.
difficile cytotoxin. All stool samples were negative for rotavirus
on ELISA tests.
The clinical characteristics of patients with and those without
diarrhea are summarized in table 4. There were no differences
between the 2 groups with regard to age, sex, comorbidities,
and chronic hepatitis B status. The manifestations on chest
radiographs at hospital admission were also similar. There were
no statistical differences in hematological and biochemical pa-
rameters between the 2 groups at presentation and on day 10
after the onset of symptoms. Patients with diarrhea had lower
potassium levels ( mmol/L) and higher mean sodium3.3 0.5
levels ( mmol/L). There was no difference in the mean143 3
virus loads in nasopharyngeal specimens (as measured by quan-
titative RT-PCR) at baseline between the groups with and with-
out diarrhea. A higher mean virus load in nasopharyngeal spec-
imens obtained on day 10 after the onset of symptoms was
significantly associated with the occurrence of diarrhea (3.1 vs.
1.8 log10 copies/mL; ) and mortality (6.2 vs. 1.7 log10Pp .01
copies/mL; ). However, there were no differences be-P ! .01
tween patients with and those without diarrhea with regard to
the incidence of intensive care admission, receipt of mechanical
ventilatory support, length of hospital stay, and overall mor-
tality. Furthermore, the severity of diarrhea had no correlation
with the virus load in nasopharyngeal specimens and overall
mortality (figure 2).
DISCUSSION
SARS is predominantly a viral pneumonia with a rapid tempo
of deterioration. However, extrapulmonary manifestations are
not uncommon. Skin rash [4], petechial cutaneous bleeding
with prolonged activated partial thromboplastin time and in-
creased d-dimer [12], impaired liver function, subclinical left
ventricular diastolic dysfunction [13], and rhabdomyolysis [14]
were occasionally reported. One of the more common pres-
entations other than respiratory symptoms is diarrhea [4, 7, 9,
15–18]. Our previous report that 170% of patients in the Amoy
Garden cohort developed diarrhea showed that fecal excretion
may be an important mode of shedding and transmission [7].
Subsequent epidemiological investigation confirmed the im-
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Table 4. Demographic characteristics of 142 patients who had severe acute respiratory syndrome with









Age, mean years  SD 38.9  13.1 41.7  14.6 .24
Sex
Male 25 31 .45
Female 44 42
Comorbidities, including chronic hepatitis B 11 (15.9) 10 (13.7) .87
Chronic hepatitis B 8 (11.6) 4 (5.5) .19
Duration of symptoms before hospital admission, mean days  SD 2.4  2.8 2.1  2.9 .59
Apparently abnormal chest radiograph finding at hospital admission 54 (78.3) 54 (74.0) .55
Multilobar involvement on initial chest radiograph 15 (21.7) 14 (19.2) .71
Virus load in nasopharyngeal specimens,a mean log10 copies/mL  SD
At hospital admission 2.3  2.8 2.1  2.9 .69
At day 10 after onset of symptoms 3.1  3.2 1.8  2.9 .01
Laboratory values at day 10 after onset of symptoms, mean  SD
Hematocrit 0.37  0.04 0.37  0.04 1.00
Lymphocyte count, 109 lymphocytes/L 0.61  0.29 0.57  0.36 .46
Sodium level, mmol/L 143  3 142  3 .02
Potassium level, mmol/L 3.3  0.5 3.5  0.5 !.01
Urea level, mmol/L 5.2  1.7 5.4  1.7 .47
Creatinine level, mmol/L 71  11 72  12 .81
Alanine aminotransferase level, IU/L 60  49 47  40 .10
Albumin level, g/L 32  3 32  4 .66
Lactate dehydrogenase level, IU/L 490  193 480  215 .82
Length of hospital stay, mean days  SD 33  11 31  10 .37
Intensive care admission 19 (27.5) 16 (21.9) .44
Receipt of mechanical ventilatory support 16 (23.2) 10 (13.7) .14
Overall mortality 14 (20.3) 11 (15.1) .41
NOTE. Data are no. (%) of patients, unless otherwise indicated.
a Determined by quantitative RT-PCR.
portance of faulty sewage systems in propagating this massive
outbreak of disease. Retrospective virological examination of
stool samples by RT-PCR confirmed the presence of the virus
in 190% of the samples obtained between day 14 and 21 after
onset of symptoms, which is almost twice the positivity rate of
the corresponding nasopharyngeal samples [8]. It is therefore
interesting to examine the role of SARS coronavirus in the
pathogenesis of diarrhea in patients with SARS.
Diarrhea is not an uncommon symptom during hospitali-
zation for patients with infectious diseases other than acute
gastroenteritis. In fact, diarrhea has been well reported in pneu-
monic illnesses other than SARS, such as legionnaires disease
[19], Pneumocystis carinii pneumonia [20], and influenza (es-
pecially in children) [21]. Moreover, diarrhea is not uncommon
in association with many systemic infections. For example, the
rate of diarrhea was reported to be 34.5% among children with
primary dengue fever [22]. The exact mechanisms leading to
diarrhea in these systemic or pulmonary infections were not
known, but they could be related to the cytokine profiles or
metabolic changes associated with sepsis. In addition to primary
viral illness, other potential causes of diarrhea include the use
of drugs during hospitalization and C. difficile superinfection,
because most patients with SARS have been empirically treated
with antibiotics that cover typical and atypical pneumonia. Fi-
nally, diarrhea can be the direct result of viral cytolysis, because
the virus can grow and produce a cytopathic effect in a large
intestinal cell line, CACO-2 [23]. A study of the correlation
between the clinical parameters, microbiological findings, and
outcomes for patients with SARS with and without diarrhea
may differentiate the relative importance of the suggested caus-
ative factors.
In this cohort of 142 patients with SARS, only 10.6% of the
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Figure 2. Frequency of bowel movements in relation to virus load in nasopharyngeal specimens on day 10 after the onset of symptoms. NPS,
nasopharyngeal specimen; qPCR, quantitative RT-PCR.
patients had diarrhea at hospital admission. During hospital-
ization, 69 (48.6%) of the patients had developed diarrhea at
a mean time of days after the onset of symptoms.7.6 2.6
The most severe diarrhea occurred 1–2 days after the onset of
diarrhea, with a maximum frequency of 24 episodes per day.
In 6 patients, diarrhea was so severe that intravenous fluid
hydration was warranted. The diarrhea was relatively painless
and watery, as we have reported previously [7]. No correlation
was found between diarrhea and hematological changes, ra-
diological changes, use of antibacterials, or isolation of C. dif-
ficile and rotavirus from stool specimens. The only significant
correlation was that there was a higher virus load in the na-
sopharyngeal specimens taken from patients with diarrhea on
day 10 after the onset of symptoms. The finding that a higher
virus load—but not the presence of diarrhea—predicted mor-
tality in this group of patients is not unexpected. In 2 previous
studies of animal models of SARS [6, 24], histological changes
of acute respiratory distress syndrome (ARDS) and inflam-
mation—characterized by diffuse alveolar damage (disruption
of alveolar walls and infiltration with neutrophils and macro-
phages), alveolar hyaline membrane formation, as well as mul-
tinucleated syncytial cells—were found in a macaque monkey
model artificially inoculated with SARS coronavirus [6]. None
of the monkeys developed diarrhea over a period of 16 days,
despite the fact that RT-PCR results were positive for SARS
coronavirus in 1 of the stool samples. Similarly, no histopath-
ological changes could be detected in the intestines of the mon-
keys, despite there being concomitant florid pathological
changes in the lungs [6]. These findings suggest that viral rep-
lication triggers a different response and thus different func-
tional impairment in the lungs and the gastrointestinal tract.
A high virus load in the nasopharynx specimens either may
predict severe pneumonia, ARDS, and mortality in some pa-
tients, or it may predict just diarrhea in other patients. This
postulation is in keeping with the lack of significant difference
in hematological markers of inflammation or increased cell
turnover (lactate dehydrogenase level) between the groups with
or without diarrhea. Although suppression of inflammatory
changes in the intestine resulting from steroid therapy is pos-
sible, the routine use of steroids and ribavirin as part of the
treatment protocol did not allow us to control the effect of use
of steroids or antivirals on diarrhea. Moreover, the use of ster-
oids has not affected the severe inflammatory reactions in the
lungs of persons who have died of SARS [25].
In our previous study, we showed that rotavirus can be de-
tected by viral isolation in cell culture and by indirect im-
munofluorescent antigen detection [10]. This is not unex-
pected, because many viruses that affect the gastrointestinal
tract also affect the respiratory tract, and vice versa. For in-
stance, in several studies, rotavirus has been well reported to
be associated with bronchiolitis and fatal pneumonitis in im-
munocompromised as well as immunocompetent hosts [11,
26, 27]. Others reported that respiratory symptoms were found
in 93% of patients with gastroenteritis caused by enteric ade-
novirus [28]. This virus has been found in samples from the
upper respiratory tract and in stool samples obtained from these
patients [29]. Similar to rotavirus and adenovirus, the SARS
coronavirus can multiply and shed in the mucosa of the upper
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aerodigestive tract. In this regard, determination of the virus
load in specimens from the nasopharynx may be useful for
predicting the severity of illness in both the respiratory and the
gastrointestinal tracts. From the laboratory perspective, RT-
PCR is more likely to be affected by the abundant inhibitors
present in stool than by nasopharyngeal secretions. Moreover,
the volume of diarrhea varies markedly from patient to patient.
This may also affect the interpretation of data on the virus load
in stool. Therefore, we attempted to use nasopharyngeal spec-
imens instead of stool specimens in this study.
Coronaviruses can cause respiratory or diarrheal diseases in
both human and animals [30–44]. Human enteric coronavirus
has been seen in diarrheal stool samples, but culture methods
and characterization are still problematic [30, 31]. Human co-
ronavirus OC43 and 229E are known to cause one-third of
cases of the common cold [45, 46]. In the case of porcine
coronavirus, a collection of transmissible gastroenteritis coro-
navirus (TGEV) recombinants were generated to study the mo-
lecular basis of TGEV tropism [47]. Recombinants of group 1
had enteric and respiratory tropism, whereas group 2 recom-
binants infected the respiratory but not the enteric tract. A
substitution in amino acid 219 of the S protein in group 1
recombinant was responsible for the loss of enteric tropism
[47]. On the other hand, targeted recombination of the S gene
of TGEV resulted in a change from respiratory to enteric tro-
pism and enhanced virulence [48]. However, no major deletion
or mutation of functional significance had been identified by
genomic sequencing of SARS coronavirus isolated from the
diarrheal patients [49].
We have clearly demonstrated the presence of a numerous
virus in tissue biopsy specimens from the terminal ileum and
colon of a SARS patient with diarrhea [9]. The virus is capable
of active replication inside the endoplasmic reticulum and ad-
heres to the surface of enterocytes in both small and large
intestines (as shown by electron microscopy), without causing
significant villous atrophy or inflammatory cell infiltration in
the mucosal or submucosal regions [9]. The absence of inflam-
mation, cell necrosis, or microvilli atrophy does not exclude
SARS coronavirus as the cause of diarrhea in these patients.
For astrovirus-associated diarrhea in turkeys, the animal model
has demonstrated mild histological changes, with a surprising
lack of inflammation due to increased activation of the potent
immunosuppressive cytokine transforming growth factor b at
the peak of diarrhea during astrovirus infection [50]. Additional
studies should be performed to ascertain the mechanism used
by SARS coronavirus in the pathogenesis of diarrhea in
humans.
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